Cumberland Pharmaceuticals (NASDAQ:CPIX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note published on Monday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Price Performance Shares of NASDAQ:CPIX opened at $2.00 on Monday. Cumberland Pharmaceuticals has a one year low of $1.43 and a […]
More Stories
2 Chinese Nationals Charged With Visa Fraud, Smuggling ‘Agroterrorism Weapon’ Into US
By Catherine Yang Two Chinese nationals, including one who works at the University of Michigan, were charged on June 2...
Boulder Attack Suspect’s Family Taken Into Federal Custody; Deportation May Be Imminent
By Janice Hisle The White House says the family of the suspect in Sunday’s terror attack in Boulder, Colorado, might...
US Sends Letters to Trade Partners to Seek ‘Best Offers’ by June 4
By Austin Alonzo The U.S. trade representative is sending “friendly reminders” that a trade negotiation deadline is coming due, White...
Dollar General Beats Trend, Lifts Guidance as Higher-Income Shoppers Seek Bargains
By Panos Mourdoukoutas Shaking off concerns raised by several retailers over a potential shortfall in sales and earnings, Dollar General...
Super Bowl Champs Ronald Darby, David Andrews Top List of High-Profile NFL Retirements
By John Rigolizzo Super Bowl Champion cornerback Ronald Darby headlines a list of high-profile NFL retirements. The Houston Texans placed...
Job Openings Unexpectedly Jump to 7.39 Million in April: JOLTS
By Andrew Moran Employment vacancies unexpectedly rose in April, reaffirming the health of the U.S. labor market. According to the...